Losartan treating podocyte injury induced by Ang II via downregulation of TRPC6 in podocytes

Conclusion:
These findings maybe provide an ideal drug target for the diagnosis and treatment of acquired glomerular diseases.

Source: Journal of the Renin-Angiotensin-Aldosterone System : JRAAS - December 23, 2015 Category: Biomedical Science Authors: Chi-Xianggeng, , Hu-Bo, , Yu, S., Yin-Lianghong, , Meng-Yu, , Wang-Boxun, , Yang-Jinsheng, , Lin-Jiahui, , Huang-Dexu, , Chen-lanlan, Tags: Original Articles Source Type: research